Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the Pancreas
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
- 主要终点
- Difference in gut microbiota composition
研究概览
简要总结
This prospective, single-center observational study investigates whether continuous glucose monitoring (CGM, 14 days) and gut microbiota composition (from a fecal sample) reveal patterns specific to pancreatic cancer, aiming to contribute to earlier detection and better assessment of disease severity. Adult patients under investigation, follow-up, or treatment for benign or malignant pancreatic/periampullary conditions are invited to participate in either or both parts of the study.
详细描述
See Appendix 1 (Research Plan) for a full description of the background, aims, and methods.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults (≥18 years of age).
- •Undergoing clinical investigation, follow-up, or treatment for a pancreatic or periampullary condition (malignant or benign/premalignant, including cystic lesions and pancreatitis).
- •Willing and able to provide written informed consent for participation in at least one component of the study (continuous glucose monitoring and/or fecal sample collection).
排除标准
- 未提供
研究组 & 干预措施
Patients with pancreatic cancer
Patients with cysts or other benign pancreatic disease
结局指标
主要结局
Difference in gut microbiota composition
时间窗: Single fecal sample
Difference in CGM-derived glycemic variability metrics
时间窗: 14 days CGM recording period
次要结局
未报告次要终点
